NEW YORK (GenomeWeb) – GIMDx announced today that it has signed an exclusive distribution agreement for IncellDx's single-cell immune-oncology and oncology diagnostic products in China.

Under the terms of the agreement, GIMDx will supply its China-based parent company Guangzhou Improve Medical Instruments with IncellDx component products, which will be kitted and co-labeled for the Chinese in vitro diagnostic market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jul
10
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.